Mainz Biomed NV (MYNZ) is around the middle of the Diagnostics & Research industry according to InvestorsObserver. MYNZ received an overall rating of 36, which means that it scores higher than 36 percent of all stocks. Mainz Biomed NV also achieved a score of 42 in the Diagnostics & Research industry, putting it above 42 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 101 out of the 148 industries.
MYNZ has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on MYNZ!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Mainz Biomed NV Stock Today?
Mainz Biomed NV (MYNZ) stock is trading at $1.30 as of 12:53 PM on Friday, Dec 1, a gain of $0.16, or 14.04% from the previous closing price of $1.14. The stock has traded between $1.13 and $1.32 so far today. Volume today is high. So far 384,485 shares have traded compared to average volume of 185,743 shares.
Click Here to get the full Stock Report for Mainz Biomed NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
